microRNA-21: a key modulator in oncogenic viral infections

被引:7
|
作者
He, Guitian [1 ,2 ]
Ding, Juntao [3 ]
Zhang, Yong'e [1 ,2 ]
Cai, Mengting [1 ,2 ]
Yang, Jing [1 ,2 ]
Cho, William C. Shing [4 ]
Zheng, Yadong [1 ,2 ,5 ]
机构
[1] CAAS, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China
[2] CAAS, Key Lab Vet Parasitol Gansu Prov, Lanzhou 730046, Gansu, Peoples R China
[3] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Peoples R China
[4] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China
[5] Jiangsu Coinnovat Ctr Prevent & Control Importan, Yangzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Microrna-21; hbv; hcv; hpv; ebv; hiv; oncolytic virus;
D O I
10.1080/15476286.2021.1880756
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncogenic viruses are associated with approximately 15% of human cancers. In viral infections, microRNAs play an important role in host-pathogen interactions. miR-21 is a highly conserved non-coding RNA that not only regulates the development of oncogenic viral diseases, but also responds to the regulation of intracellular signal pathways. Oncogenic viruses, including HBV, HCV, HPV, and EBV, co-evolve with their hosts and cause persistent infections. The upregulation of host miR-21 manipulates key cellular pathways to evade host immune responses and then promote viral replication. Thus, a better understanding of the role of miR-21 in viral infections may help us to develop effective genetically-engineered oncolytic virus-based therapies against cancer.
引用
收藏
页码:809 / 817
页数:9
相关论文
共 50 条
  • [21] MicroRNA-21 and the Vulnerability of Atherosclerotic Plaques
    Barwari, Temo
    Rienks, Marieke
    Mayr, Manuel
    MOLECULAR THERAPY, 2018, 26 (04) : 938 - 940
  • [22] microRNA-21 expression analysis in mice
    Syed, Maryam
    Ball, Jana
    Miguel-Hidalgo, Jose
    Romero, Damian
    FASEB JOURNAL, 2014, 28 (01):
  • [23] URINARY microRNA-21 EXPRESSION IN NEPHROPATHIES
    Smirnov, Alexey
    Zarayski, Mikhail
    Kayukov, Ivan
    Karunnaya, Hanna
    Sipovski, Vassiliy
    Kukoleva, Larisa
    Dobronravov, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 350 - 350
  • [24] MicroRNA-21研究进展
    黄霄
    郝兆虎
    医疗装备, 2020, 33 (05) : 196 - 199
  • [25] MicroRNA-21表达调控研究
    田俊梅
    涂真珍
    顾月清
    药物生物技术, 2012, 19 (01) : 65 - 69
  • [26] Emerging role of microRNA-21 in cancer
    Feng, Yin-Hsun
    Tsao, Chao-Jung
    BIOMEDICAL REPORTS, 2016, 5 (04) : 395 - 402
  • [27] MicroRNA-21 as a Novel Therapeutic Target
    Sachdeva, Mohit
    Zhu, Shoumin
    Mo, Yin-Yuan
    CURRENT CANCER THERAPY REVIEWS, 2010, 6 (01) : 41 - 50
  • [28] MicroRNA-21 facilitates osteoblast activity
    Oka, Shunichi
    Li, Xiaoyan
    Zhang, Fengzhu
    Tewari, Nitesh
    Ma, Ri
    Zhong, Liangjun
    Makishima, Makoto
    Liu, Yi
    Bhawal, Ujjal K.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 25
  • [29] MicroRNA-21 Affects Platelets and Their Releasate: A Novel Mechanism for the Anti-Fibrotic Effects of MicroRNA-21 Inhibition
    Barwari, Temo
    Eminaga, Seda
    Lu, Ruifang
    Armstrong, Paul C.
    Schulte, Christian
    Lynch, Marc
    Chan, Melissa V.
    Barallobre-Barreiro, Javier
    Yin, Xiaoke
    Pechlaner, Raimund
    Langley, Sarah
    Sahraei, M.
    Fernandez-Fuertes, M.
    Zampetaki, A.
    Santer, P.
    Warner, T. D.
    Kiechl, S.
    Willeit, J.
    Fernandez-Hernando, C.
    Suarez, Y.
    Shah, A. M.
    Mayr, M.
    CIRCULATION RESEARCH, 2018, 123
  • [30] Increased precursor microRNA-21 following status epilepticus can compete with mature microRNA-21 to alter translation
    Chak, Kayam
    Roy-Chaudhuri, Biswajoy
    Kim, Hak Kyun
    Kemp, Kayla C.
    Porter, Brenda E.
    Kay, Mark A.
    EXPERIMENTAL NEUROLOGY, 2016, 286 : 137 - 146